{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:58:56Z","timestamp":1794643136459,"version":"4.9.1"},"reference-count":17,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,8,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Human T-cell leukemia virus type 1\u2013associated adult T-cell leukemia\/lymphoma (ATL) typically has survivals measured in months with chemotherapy. One prior published series (1983-1991) assessed local radiotherapy for ATL. Ten consecutive patients with pathologically confirmed ATL treated with radiotherapy were reviewed. Subtypes included acute (n = 7), smoldering (n = 2), and lymphomatous (n = 1). Patients received an average of 2.5 systemic therapy regimens before radiotherapy. Twenty lesions (cutaneous = 10, nodal = 8, extranodal = 2) were treated to a mean of 35.4 Gy\/2-3 Gy (range, 12-60 Gy). At 9.0-month mean follow-up (range, 0.1-42.0 months), all lesions symptomatically and radiographically responded, with in-field complete responses in 40.0% (nodal 37.5% vs cutaneous 50.0%; P = .62). No patient experienced in-field progression. Nine patients developed new\/progressive out-of-field disease. Median survival was 17.0 months (3-year survival, 30.0%). No Radiation Therapy Oncology Group acute grade \u2265 3 or any late toxicity was noted. This report is the first to use modern radiotherapy techniques and finds effective local control across ATL subtypes. Radiotherapy should be considered for symptomatic local progression of ATL.<\/jats:p>","DOI":"10.1182\/blood-2012-01-401349","type":"journal-article","created":{"date-parts":[[2012,6,23]],"date-time":"2012-06-23T00:21:08Z","timestamp":1340410868000},"page":"1816-1819","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":17,"title":["Radiation therapy for the management of patients with HTLV-1\u2013associated adult T-cell leukemia\/lymphoma"],"prefix":"10.1182","volume":"120","author":[{"suffix":"II","given":"Charles B.","family":"Simone","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA;"},{"name":"Radiation Oncology Branch and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[{"name":"Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;"},{"name":"Division of Hematology-Oncology, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donn M.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole E.","family":"Urquhart","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of the West Indies, Mona, Jamaica; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Janik","sequence":"additional","affiliation":[{"name":"Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Kreitman","sequence":"additional","affiliation":[{"name":"Clinical Immunotherapy Section, Laboratory of Molecular Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Lita","sequence":"additional","affiliation":[{"name":"Radiation Oncology Branch and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Conlon","sequence":"additional","affiliation":[{"name":"Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilian","family":"Wharfe","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of the West Indies, Mona, Jamaica; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Waldmann","sequence":"additional","affiliation":[{"name":"Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aradhana","family":"Kaushal","sequence":"additional","affiliation":[{"name":"Radiation Oncology Branch and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111809143684300_B1","doi-asserted-by":"crossref","first-page":"e4420","DOI":"10.1371\/journal.pone.0004420","article-title":"AIDS Malignancy Consortium. Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma.","volume":"4","author":"Ratner","year":"2009","journal-title":"PLoS One"},{"issue":"12","key":"2019111809143684300_B2","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/onc.2010.537","article-title":"Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.","volume":"30","author":"Matsuoka","year":"2011","journal-title":"Oncogene"},{"issue":"4","key":"2019111809143684300_B3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11899-007-0035-x","article-title":"Adult T-cell leukemia\/lymphoma and HTLV-1.","volume":"2","author":"Mahieux","year":"2007","journal-title":"Curr Hematol Malig Rep"},{"issue":"7","key":"2019111809143684300_B4","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1182\/blood-2011-03-345702","article-title":"How I treat adult T-cell leukemia\/lymphoma.","volume":"118","author":"Bazarbachi","year":"2011","journal-title":"Blood"},{"issue":"39","key":"2019111809143684300_B5","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1038\/sj.onc.1208979","article-title":"Natural history of adult T-cell leukemia\/lymphoma and approaches to therapy.","volume":"24","author":"Taylor","year":"2005","journal-title":"Oncogene"},{"issue":"11","key":"2019111809143684300_B6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1470-2045(04)01608-0","article-title":"New therapeutic approaches for adult T-cell leukaemia.","volume":"5","author":"Bazarbachi","year":"2004","journal-title":"Lancet Oncol"},{"issue":"3","key":"2019111809143684300_B7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting.","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019111809143684300_B8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1743-7563.2010.01320.x","article-title":"Adult T-cell leukemia\/lymphoma in Taiwan: an analysis of 17 patients and review of the literature.","volume":"6","author":"Lee","year":"2010","journal-title":"Asia Pac J Clin Oncol"},{"issue":"3","key":"2019111809143684300_B9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases.","volume":"23","author":"Gon\u00e7alves","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"2019111809143684300_B10","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"issue":"14","key":"2019111809143684300_B11","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1002\/cncr.25147","article-title":"A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia\/lymphoma: a multicenter clinicopathologic experience and new prognostic score.","volume":"116","author":"Phillips","year":"2010","journal-title":"Cancer"},{"issue":"8","key":"2019111809143684300_B12","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study.","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood"},{"issue":"25","key":"2019111809143684300_B13","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International T-Cell Lymphoma Project. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes.","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111809143684300_B14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/bmt.2010.92","article-title":"ATLL allo-HSCT Study Group. Long-term outcomes after hematopoietic SCT for adult T-cell leukemia\/lymphoma: results of prospective trials.","volume":"46","author":"Choi","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2019111809143684300_B15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.leukres.2010.08.006","article-title":"Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia\/lymphoma.","volume":"35","author":"Beltran","year":"2011","journal-title":"Leuk Res"},{"issue":"5","key":"2019111809143684300_B16","first-page":"248","article-title":"The role of radiation therapy in adult T-cell leukemia.","volume":"6","author":"Baba","year":"1988","journal-title":"Radiat Med"},{"issue":"6","key":"2019111809143684300_B17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/02841869409121780","article-title":"Radiation therapy of adult T-cell leukemia.","volume":"33","author":"Baba","year":"1994","journal-title":"Acta Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/9\/1816\/1363267\/zh803512001816.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/9\/1816\/1363267\/zh803512001816.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T10:19:18Z","timestamp":1574072358000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/9\/1816\/30898\/Radiation-therapy-for-the-management-of-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,30]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,8,30]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-01-401349","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,30]]}}}